About Index Trending news
Analyze
Top 50 Pricing
Neuraltus Pharmaceuticals

Neuraltus Pharmaceuticals

Work at Neuraltus Pharmaceuticals? Add yourself to this profile

Neuraltus Pharmaceuticals

Neuraltus Pharmaceuticals is focused on developing therapeutics that meetcritical unmet needs in treating neurodegenerative diseases.

Elsewhere

Alexa global traffic share

Latest funding Show all
Venture capital (Series UNDISCLOSED)
$14,940,000
Venture capital
$1,501,000
Adams Street Partners, Latterell Venture Partners
Employees

Unknown size

Locations
HQ

No recent coverage

Index constantly checks hot and trending companies for their latest activity. We haven't gotten to this company yet, but if you follow it you'll be the the first to know when Neuraltus Pharmaceuticals makes some noise.